Kensington Capital Acquisition Corp. IV announced the pricing of its $200 million IPO and its units are expected to begin trading on the NYSE under the symbol “KCAC.U” Wednesday, March 2.
The new SPAC intends to focus its search in the global automotive and automotive-related sector with a specific focus on the automotive aftermarket, emerging technologies and original equipment manufacturer and original equipment suppliers. Kensington Capital IV is led by CEO and Chairman Justin Mirro, Vice Chairman and President Dieter Zetsche, COO Robert Remenar, CTO Simon Boag, and CFO Daniel Huber.
Total SPAC deal count for 2022 year-to-date is now 48. This offering is expected to close on Friday, March 5.
UBS Investment Bank and Stifel are acting as the joint book-running managers for the offering and Baird is the lead manager of the offering with Drexel Hamilton as the co-manager. Hughes Hubbard & Reed LLP is serving as Issuer’s Counsel with Skadden, Arps, Slate, Meagher & Flom LLP serving as Underwriter’s Counsel. Marcum LLP serves as an auditor. Continental Stock Transfer & Trust Company is acting as trustee.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...